Celyad Oncology S.A.

CYAD.BR · BRU
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents€790€4,200€6,229€7,004
Short-Term Investments€0€0€0€0
Receivables€760€908€74€380
Inventory€255€417€0€0
Other Curr. Assets€0€0€1,050€2,400
Total Curr. Assets€2,457€6,515€8,662€11,121
Property Plant & Equip (Net)€1,337€1,493€1,669€1,830
Goodwill€0€0€427€0
Intangibles€357€405€26€48
Long-Term Investments€1,468€1,420€1,946€2,804
Tax Assets€0€0€1-€2,462
Other NC Assets€79€95€115€2,941
Total NC Assets€3,241€3,413€4,184€5,161
Other Assets€0€0€0€0
Total Assets€5,698€9,928€12,846€16,282
Liabilities
Payables€921€1,233€1,060€1,243
Short-Term Debt€77€142€155€156
Tax Payable€0€0€0€0
Deferred Revenue€654€785€0€509
Other Curr. Liab.€1,717€175€740€372
Total Curr. Liab.€3,719€2,846€2,416€2,932
LT Debt€0€16,631€0€16,631
Deferred Rev, NC€4,258€4,291€0€4,576
Deferred Tax Liab, NC€0€0€0€0
Other NC Liab.€68€1,517€6,331€1,568
Total NC Liab.€5,080€23,202€7,165€23,677
Other Liabilities€0€0€0-€16,631
Cap. Leases€0€905€989€1,058
Total Liabilities€8,799€26,048€9,581€9,978
Equity
Pref Stock€0€0€0€0
Common Stock€8,216€8,216€8,216€32,949
Retained Earnings-€367,871-€364,196-€361,417-€358,372
AOCI€356,554€339,860€356,466€331,727
Other Equity€0€0€0€0
Total Equity-€3,101-€16,120€3,265€6,304
Supplemental Information
Minority Interest€0€0€0€0
Total Liab. & Tot. Equity€5,698€9,928€12,846€16,282
Net Debt-€713€12,573-€6,074€9,783